Motley Fool Wealth Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10M | Buy |
|
|||||
|
2025
Q1 | $5.42M | Sell |
|
|||||
|
2024
Q4 | $6.43M | Sell |
|
|||||
|
2024
Q3 | $9.33M | Sell |
|
|||||
|
2024
Q2 | $7.01M | Buy |
|
|||||
|
2024
Q1 | $7.66M | Sell |
|
|||||
|
2023
Q4 | $7.86M | Sell |
|
|||||
|
2023
Q3 | $6M | Buy |
|
|||||
|
2023
Q2 | $5.08M | Buy |
|
|||||
|
2023
Q1 | $4.42M | Buy |
|
|||||
|
2022
Q4 | $2.54M | Sell |
|
|||||
|
2022
Q3 | $2.32M | Buy |
|
|||||
|
2022
Q2 | $3.34M | Sell |
|
|||||
|
2022
Q1 | $4.08M | Buy |
|
|||||
|
2021
Q4 | $4.72M | Sell |
|
|||||
|
2021
Q3 | $5.24M | Sell |
|
|||||
|
2021
Q2 | $5.65M | Sell |
|
|||||
|
2021
Q1 | $6.8M | Buy |
|